Scleroderma mimics - Clinical features and management.
- Resource Type
- Academic Journal
- Authors
- Orteu CH; Department of Dermatology, Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, UK.; Ong VH; Centre for Rheumatology, Royal Free Campus, University College London, Rowland Hill Street, London NW3 2PF, UK.; Denton CP; Centre for Rheumatology, Royal Free Campus, University College London, Rowland Hill Street, London NW3 2PF, UK. Electronic address: c.denton@ucl.ac.uk.
- Source
- Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101121149 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1770 (Electronic) Linking ISSN: 15216942 NLM ISO Abbreviation: Best Pract Res Clin Rheumatol Subsets: MEDLINE
- Subject
- Language
- English
Systemic sclerosis is a severe immune-mediated rheumatic disease by virtue of its clinical impact and mortality. There are a number of other sclerosing skin diseases that should be considered in the differential diagnosis and these are important because they may require specialist investigation and management. In addition, long-term follow up of the different conditions should reflect the risk of associated complications and anticipated duration of therapy. This article reviews the clinical features of potential mimics of scleroderma (systemic sclerosis) including localised forms of scleroderma (morphoea) and other conditions that lead to skin thickening and connective tissue fibrosis or scarring.
Competing Interests: Declaration of Competing Interest None.
(Copyright © 2020 Elsevier Ltd. All rights reserved.)